Apixaban and Bemiparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Bemiparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of your medicines are blood thinners. Apixaban (Eliquis) and bemiparin work in different ways, but they both make your blood clot more slowly. Taking them together adds their effects up, so your risk of bleeding goes up, and in some cases that bleeding can be serious.
This does not mean the combination is never used, but it is something your care team watches closely. Please watch for signs of bleeding: unusual bruising, pink or red urine, black or bloody stools, nosebleeds that won't stop, or bleeding gums. If you notice any of these, or feel dizzy or very weak, call your doctor right away or go to the emergency room. Your care team can manage this safely by tailoring your doses and keeping an eye on you.
Additive anticoagulation. Apixaban (direct factor Xa inhibitor) plus bemiparin (low molecular weight heparin, indirect anti-FXa activity) produces additive antithrombotic effect and increased bleeding risk. Neither is a prodrug; effect is pharmacodynamic, not metabolic.
- Magnitude: a 50-60% increase in anti-FXa activity was seen with apixaban plus enoxaparin; expect a comparable additive effect with bemiparin.
- Evidence/severity: probable, major.
- Management: avoid overlap unless clinically indicated; discontinue apixaban if active pathological bleeding occurs. Apixaban PD effect persists at least 24 hours after last dose. A specific reversal agent for anti-FXa activity is available; PCC, aPCC, or recombinant factor VIIa may be considered. During PCC use, PT/INR/aPTT and anti-FXa monitoring are not useful. Activated charcoal reduces apixaban absorption.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
Taking apixaban, a factor Xa inhibitor, together with another anticoagulant raises the likelihood of bleeding. Pharmacodynamic interaction studies with apixaban demonstrated that giving apixaban alongside enoxaparin produced a 50% to 60% rise in anti-factor Xa activity. If active pathological bleeding develops, apixaban should be stopped. A product capable of reversing apixaban's anti-factor Xa activity exists. Apixaban's pharmacodynamic action is anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled about the signs and symptoms of blood loss and instructed to report these right away or seek an emergency room. Options that may be considered include prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa. If PCCs are administered, tracking apixaban's anticoagulant effect through a clotting test (PT, INR, or aPTT) or anti-factor Xa (FXa) activity is neither helpful nor recommended. Activated oral charcoal decreases apixaban absorption and consequently reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
The main concern is added bleeding risk because both drugs thin the blood. Keep taking both exactly as prescribed and do not start or stop either one on your own.
- Your care team may adjust and individualize your doses and monitor you more closely while you are on both.
- Learn the signs of bleeding: unusual bruising, red or dark urine, black or bloody stools, coughing or vomiting blood, prolonged nosebleeds, severe headache, or feeling faint.
- Report any of these immediately or go to an emergency room.
Reassuringly, this is manageable: reversal agents for apixaban's anti-factor Xa activity exist, and your team knows how to handle bleeding if it occurs. Ask your pharmacist or prescriber any time you're unsure.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations examining pharmacodynamic drug interactions involving apixaban, an increase of 50% to 60% in anti-factor Xa activity was noted when apixaban and enoxaparin were given together 1.
Common questions
Can I take Apixaban and Bemiparin together?
Apixaban and bemiparin are both blood thinners, so using them together raises the risk of serious bleeding. Keep taking both as prescribed, watch closely for any bleeding signs, and get emergency help if they appear. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Apixaban and Bemiparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Apixaban and Bemiparin interaction managed?
The main concern is added bleeding risk because both drugs thin the blood. Keep taking both exactly as prescribed and do not start or stop either one on your own. Your care team may adjust and individualize your doses and monitor you more closely while you are on both. Learn the signs of bleeding: unusual bruising, red or dark urine, black or bloody stools, coughing or vomiting blood, prolonged no… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Apixaban or Bemiparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Bemiparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist